Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Arm B: A combination of pentoxifylline and tocopherol acetate in addition to best standard care [a structured programme of rehabilitation exercises] for 6 months
United Therapeutics Europe Ltd
Head and Neck Fibrosis
1 trial -
Atovaquone Oral Suspension
United Therapeutics Europe Ltd
Locally Advanced Non-Small Cell Lung Cancer
1 trial -
Autologous Engineered Urethral Construct
United Therapeutics Europe Ltd
Urologic Diseases
1 trial -
Autologous Human Schwann Cell
United Therapeutics Europe Ltd
Peripheral Nerve Injury
1 trial -
Autologous tissue engineered corpora
United Therapeutics Europe Ltd
Urologic Diseases
1 trial -
BIO 300 Oral Powder
United Therapeutics Europe Ltd
Acute Radiation Syndrome
1 trial -
Biospecimen Collection
United Therapeutics Europe Ltd
Glioma
1 trial -
CABG + Mitral valve annuloplasty
United Therapeutics Europe Ltd
Mitral Regurgitation
1 trial -
CCT3833
United Therapeutics Europe Ltd
Melanoma
1 trial -
CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
United Therapeutics Europe Ltd
HER2 Negative Breast Carcinoma
1 trial -
CE marked Philips Motiva system
United Therapeutics Europe Ltd
COPD
1 trial -
CHR-2797 (tosedostat)
United Therapeutics Europe Ltd
Advanced Solid Tumors
1 trial -
COVID-HIG
United Therapeutics Europe Ltd
SARS-CoV-2 Infection
1 trial -
COVID-HIGIV
United Therapeutics Europe Ltd
COVID-19
1 trial -
CXD101
United Therapeutics Europe Ltd
Advanced Cancer
1 trial -
Cabozantinib Oral Tablet
United Therapeutics Europe Ltd
Neurofibromatosis 1
1 trial -
Cam2020 M2SR H3N2 influenza vaccine
United Therapeutics Europe Ltd
Influenza Vaccine
1 trial -
Campylobacter jejuni strain CG8421
United Therapeutics Europe Ltd
Campylobacter Infections
1 trial -
Carbidopa
United Therapeutics Europe Ltd
Multiple Sclerosis
1 trial -
Chlorhexidine
United Therapeutics Europe Ltd
Peri-Implantitis
1 trial -
Cisplatin
United Therapeutics Europe Ltd
Advanced Cholangiocarcinoma
1 trial -
Clinical Center Reference Endotoxin (CCRE)
United Therapeutics Europe Ltd
Healthy
1 trial -
Cyclophosphamide
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
D/ChAd63-CA
United Therapeutics Europe Ltd
Malaria
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources